Premium
Homegrown private equity firm ChrysCapital has increased its exposure to a pharmaceutical company in which it re-entered as an investor a couple of months ago after exiting three years earlier. ChrysCapital bought about 1.8 million shares, or a 1.3% stake, in Eris Lifesciences Ltd on Friday for Rs 65 crore. The ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
